Epidarex Capital

Epidarex Capital logo

Epidarex Capital (formerly Rock Spring Ventures) invests in early-stage, high growth life science and health technology companies in under-ventured markets within the UK and US. Epidarex funds the commercialization of ground-breaking research and new technologies to address large and unmet needs in today's healthcare market.

Contact Epidarex Capital via their website

News archive

10/04/2019   Epidarex Capital Reports NodThera Progress and Key Additions to Board...more
09/04/2019   Epidarex Capital Reports Appointment of David Chiswell at IGEM Therapeutics...more
25/03/2019   Epidarex Capital Reports Appointment of Amit D. Munshi to Enterprise Therapeutics...more
22/03/2019   Epidarex Capital Continues Expansion of its Team...more
28/02/2019   Epidarex Capital's AdoRx Therapeutics Announces J&J Innovation Collaboration...more

25/09/2018   Epidarex Capital joins the BioPartner programme...more

The BioPartner Programme

BPP members enjoy our full range of discounts, enhanced promotion on BioPartner UK Delegations and first refusal on new international opportunities.

Not a member? Join the BioPartnership Programme

BioPartner UK is a member of

Sponsors Alliance

Prompt Payment Code